Ankylosing Spondylitis Drug Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0080902
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.49
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.49 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
SummaryAnkylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.
The global Ankylosing Spondylitis Drug market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.
This report studies the Ankylosing Spondylitis Drug market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Ankylosing Spondylitis Drug in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
By the product type, the market is primarily split into
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
By the end users/application, this report covers the following segments
Hospitals
Clinics
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Ankylosing Spondylitis Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of Ankylosing Spondylitis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ankylosing Spondylitis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ankylosing Spondylitis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Ankylosing Spondylitis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Ankylosing Spondylitis Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ankylosing Spondylitis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Ankylosing Spondylitis Drug market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents
1 Ankylosing Spondylitis Drug Market Overview
1.1 Ankylosing Spondylitis Drug Product Overview
1.2 Ankylosing Spondylitis Drug Market Segment by Type
1.2.1 Cimzia
1.2.2 Enbrel
1.2.3 Humira
1.2.4 Remicade
1.2.5 Simponi
1.2.6 Others
1.3 Global Ankylosing Spondylitis Drug Market Size by Type
1.3.1 Global Ankylosing Spondylitis Drug Sales and Growth by Type
1.3.2 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2014-2019)
1.3.3 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2014-2019)
1.3.4 Global Ankylosing Spondylitis Drug Price by Type (2014-2019)
2 Global Ankylosing Spondylitis Drug Market Competition by Company
2.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Company (2014-2019)
2.2 Global Ankylosing Spondylitis Drug Revenue and Share by Company (2014-2019)
2.3 Global Ankylosing Spondylitis Drug Price by Company (2014-2019)
2.4 Global Top Players Ankylosing Spondylitis Drug Manufacturing Base Distribution, Sales Area, Product Types
2.5 Ankylosing Spondylitis Drug Market Competitive Situation and Trends
2.5.1 Ankylosing Spondylitis Drug Market Concentration Rate
2.5.2 Global Ankylosing Spondylitis Drug Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Ankylosing Spondylitis Drug Company Profiles and Sales Data
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.1.3 Amgen Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Wyeth
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Takeda
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.3.3 Takeda Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Centocor
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.4.3 Centocor Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Schering-Plough
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Mitsubishi Tanabe
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Abbott
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.7.3 Abbott Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Eisai
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.8.3 Eisai Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Pfizer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Johnson & Johnson
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 Ankylosing Spondylitis Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Ankylosing Spondylitis Drug Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Ankylosing Spondylitis Drug Sales and Revenue by Regions
4.2.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Regions (2014-2019)
4.2.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Ankylosing Spondylitis Drug Application/End Users
5.1 Ankylosing Spondylitis Drug Segment by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Ankylosing Spondylitis Drug Product Segment by Application
5.2.1 Global Ankylosing Spondylitis Drug Sales by Application
5.2.2 Global Ankylosing Spondylitis Drug Sales and Market Share by Application (2014-2019)
6 Global Ankylosing Spondylitis Drug Market Forecast
6.1 Global Ankylosing Spondylitis Drug Sales, Revenue Forecast (2019-2025)
6.1.1 Global Ankylosing Spondylitis Drug Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Ankylosing Spondylitis Drug Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Ankylosing Spondylitis Drug Forecast by Regions
6.2.1 North America Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Ankylosing Spondylitis Drug Forecast by Type
6.3.1 Global Ankylosing Spondylitis Drug Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Cimzia Gowth Forecast
6.3.3 Enbrel Gowth Forecast
6.4 Ankylosing Spondylitis Drug Forecast by Application
6.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2019-2025)
6.4.2 Global Ankylosing Spondylitis Drug Forecast in Hospitals
6.4.3 Global Ankylosing Spondylitis Drug Forecast in Clinics
7 Ankylosing Spondylitis Drug Upstream Raw Materials
7.1 Ankylosing Spondylitis Drug Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Ankylosing Spondylitis Drug Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Ankylosing Spondylitis Drug Product Picture
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Cimzia
Table Major Players of Cimzia
Figure Global Cimzia Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Enbrel
Table Major Players of Enbrel
Figure Global Enbrel Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Humira
Table Major Players of Humira
Figure Global Humira Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Remicade
Table Major Players of Remicade
Figure Global Remicade Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Simponi
Table Major Players of Simponi
Figure Global Simponi Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Type in 2018
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Type
Table Global Ankylosing Spondylitis Drug Price (USD/Unit) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Company (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Share (%) by Company in 2018
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Company (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Share (%) by Company in 2018
Table Global Market Ankylosing Spondylitis Drug Average Price (USD/Unit) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Ankylosing Spondylitis Drug Top Players Product Category
Figure Global Ankylosing Spondylitis Drug Market Share (%) of Top 5 Players
Figure Global Ankylosing Spondylitis Drug Market Share (%) of Top 10 Players
Table Amgen Basic Information List
Table Amgen Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Amgen Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Amgen Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Amgen Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Wyeth Basic Information List
Figure Wyeth Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Wyeth Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Wyeth Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Wyeth Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Takeda Basic Information List
Figure Takeda Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Takeda Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Takeda Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Takeda Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Centocor Basic Information List
Figure Centocor Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Centocor Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Centocor Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Centocor Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Schering-Plough Basic Information List
Figure Schering-Plough Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Schering-Plough Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Mitsubishi Tanabe Basic Information List
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Abbott Basic Information List
Figure Abbott Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Abbott Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Abbott Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Abbott Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Eisai Basic Information List
Figure Eisai Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Eisai Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eisai Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Eisai Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Pfizer Basic Information List
Figure Pfizer Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Pfizer Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Pfizer Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Johnson & Johnson Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Global Ankylosing Spondylitis Drug Market Size Comparison by Regions (2014-2025)
Figure North America Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Regions (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions
Table Global Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Ankylosing Spondylitis Drug Sales Growth Rate
Table North America Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure United States Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Canada Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Canada Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Mexico Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Mexico Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Europe Ankylosing Spondylitis Drug Sales Growth Rate
Table Europe Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Germany Ankylosing Spondylitis Drug Revenue (Million USD) (2014-2019)
Figure UK Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure UK Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure France Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure France Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Italy Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Italy Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Russia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Russia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Turkey Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Turkey Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Ankylosing Spondylitis Drug Sales Growth Rate
Table Asia-Pacific Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure China Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Japan Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Korea Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Korea Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Indonesia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Indonesia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Thailand Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Thailand Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Malaysia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Malaysia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Philippines Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Philippines Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Vietnam Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Vietnam Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure India Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure India Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Australia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Australia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure South America Ankylosing Spondylitis Drug Sales Growth Rate
Table South America Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Brazil Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Ankylosing Spondylitis Drug Sales Growth Rate
Table Middle East and Africa Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure North Africa Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure GCC Countries Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure GCC Countries Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Hospitals Examples
Figure Clinics Examples
Table Global Ankylosing Spondylitis Drug Sales (K Units) Comparison by Application (2014-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Application (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Application (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Application (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Application in 2018
Figure Global Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Ankylosing Spondylitis Drug Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Cimzia Sales Growth Forecast
Figure Enbrel Sales Growth Forecast
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Forecast by Application (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Forecast in Hospitals
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Forecast in Clinics
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Ankylosing Spondylitis Drug Manufacturing Cost Structure
Figure Ankylosing Spondylitis Drug Industrial Chain Analysis
Table Distributors List
Table Ankylosing Spondylitis Drug Downstream Customers
1 Ankylosing Spondylitis Drug Market Overview
1.1 Ankylosing Spondylitis Drug Product Overview
1.2 Ankylosing Spondylitis Drug Market Segment by Type
1.2.1 Cimzia
1.2.2 Enbrel
1.2.3 Humira
1.2.4 Remicade
1.2.5 Simponi
1.2.6 Others
1.3 Global Ankylosing Spondylitis Drug Market Size by Type
1.3.1 Global Ankylosing Spondylitis Drug Sales and Growth by Type
1.3.2 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2014-2019)
1.3.3 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2014-2019)
1.3.4 Global Ankylosing Spondylitis Drug Price by Type (2014-2019)
2 Global Ankylosing Spondylitis Drug Market Competition by Company
2.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Company (2014-2019)
2.2 Global Ankylosing Spondylitis Drug Revenue and Share by Company (2014-2019)
2.3 Global Ankylosing Spondylitis Drug Price by Company (2014-2019)
2.4 Global Top Players Ankylosing Spondylitis Drug Manufacturing Base Distribution, Sales Area, Product Types
2.5 Ankylosing Spondylitis Drug Market Competitive Situation and Trends
2.5.1 Ankylosing Spondylitis Drug Market Concentration Rate
2.5.2 Global Ankylosing Spondylitis Drug Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Ankylosing Spondylitis Drug Company Profiles and Sales Data
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.1.3 Amgen Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Wyeth
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Takeda
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.3.3 Takeda Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Centocor
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.4.3 Centocor Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Schering-Plough
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Mitsubishi Tanabe
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Abbott
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.7.3 Abbott Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Eisai
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.8.3 Eisai Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Pfizer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Johnson & Johnson
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Ankylosing Spondylitis Drug Product Category, Application and Specification
3.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 Ankylosing Spondylitis Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Ankylosing Spondylitis Drug Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Ankylosing Spondylitis Drug Sales and Revenue by Regions
4.2.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Regions (2014-2019)
4.2.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Ankylosing Spondylitis Drug Application/End Users
5.1 Ankylosing Spondylitis Drug Segment by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Ankylosing Spondylitis Drug Product Segment by Application
5.2.1 Global Ankylosing Spondylitis Drug Sales by Application
5.2.2 Global Ankylosing Spondylitis Drug Sales and Market Share by Application (2014-2019)
6 Global Ankylosing Spondylitis Drug Market Forecast
6.1 Global Ankylosing Spondylitis Drug Sales, Revenue Forecast (2019-2025)
6.1.1 Global Ankylosing Spondylitis Drug Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Ankylosing Spondylitis Drug Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Ankylosing Spondylitis Drug Forecast by Regions
6.2.1 North America Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Ankylosing Spondylitis Drug Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Ankylosing Spondylitis Drug Forecast by Type
6.3.1 Global Ankylosing Spondylitis Drug Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Cimzia Gowth Forecast
6.3.3 Enbrel Gowth Forecast
6.4 Ankylosing Spondylitis Drug Forecast by Application
6.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2019-2025)
6.4.2 Global Ankylosing Spondylitis Drug Forecast in Hospitals
6.4.3 Global Ankylosing Spondylitis Drug Forecast in Clinics
7 Ankylosing Spondylitis Drug Upstream Raw Materials
7.1 Ankylosing Spondylitis Drug Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Ankylosing Spondylitis Drug Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Ankylosing Spondylitis Drug Product Picture
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Cimzia
Table Major Players of Cimzia
Figure Global Cimzia Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Enbrel
Table Major Players of Enbrel
Figure Global Enbrel Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Humira
Table Major Players of Humira
Figure Global Humira Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Remicade
Table Major Players of Remicade
Figure Global Remicade Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Simponi
Table Major Players of Simponi
Figure Global Simponi Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Type in 2018
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Type (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Type
Table Global Ankylosing Spondylitis Drug Price (USD/Unit) by Type (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Company (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Share (%) by Company in 2018
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Share (%) by Company (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Share (%) by Company in 2018
Table Global Market Ankylosing Spondylitis Drug Average Price (USD/Unit) by Company (2014-2019)
Table Global Ankylosing Spondylitis Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Ankylosing Spondylitis Drug Top Players Product Category
Figure Global Ankylosing Spondylitis Drug Market Share (%) of Top 5 Players
Figure Global Ankylosing Spondylitis Drug Market Share (%) of Top 10 Players
Table Amgen Basic Information List
Table Amgen Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Amgen Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Amgen Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Amgen Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Wyeth Basic Information List
Figure Wyeth Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Wyeth Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Wyeth Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Wyeth Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Takeda Basic Information List
Figure Takeda Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Takeda Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Takeda Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Takeda Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Centocor Basic Information List
Figure Centocor Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Centocor Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Centocor Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Centocor Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Schering-Plough Basic Information List
Figure Schering-Plough Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Schering-Plough Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Schering-Plough Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Mitsubishi Tanabe Basic Information List
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Abbott Basic Information List
Figure Abbott Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Abbott Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Abbott Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Abbott Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Eisai Basic Information List
Figure Eisai Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Eisai Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eisai Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Eisai Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Pfizer Basic Information List
Figure Pfizer Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Pfizer Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Pfizer Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson Ankylosing Spondylitis Drug Product Category, Application and Specification
Table Johnson & Johnson Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Growth Rate (2014-2019)
Figure Johnson & Johnson Ankylosing Spondylitis Drug Sales Global Market Share (%)(2014-2019)
Table Global Ankylosing Spondylitis Drug Market Size Comparison by Regions (2014-2025)
Figure North America Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Regions (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Sales Market Share (%) by Regions
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions (2014-2019)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Ankylosing Spondylitis Drug Revenue Market Share (%) by Regions
Table Global Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Ankylosing Spondylitis Drug Sales Growth Rate
Table North America Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure United States Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Canada Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Canada Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Mexico Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Mexico Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Europe Ankylosing Spondylitis Drug Sales Growth Rate
Table Europe Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Germany Ankylosing Spondylitis Drug Revenue (Million USD) (2014-2019)
Figure UK Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure UK Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure France Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure France Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Italy Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Italy Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Russia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Russia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Turkey Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Turkey Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Ankylosing Spondylitis Drug Sales Growth Rate
Table Asia-Pacific Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure China Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Japan Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Korea Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Korea Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Indonesia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Indonesia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Thailand Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Thailand Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Malaysia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Malaysia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Philippines Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Philippines Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Vietnam Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Vietnam Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure India Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure India Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Australia Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Australia Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure South America Ankylosing Spondylitis Drug Sales Growth Rate
Table South America Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure Brazil Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Ankylosing Spondylitis Drug Sales Growth Rate
Table Middle East and Africa Ankylosing Spondylitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure North Africa Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure GCC Countries Ankylosing Spondylitis Drug Sales (K Units)(2014-2019)
Figure GCC Countries Ankylosing Spondylitis Drug Revenue (Million USD)(2014-2019)
Figure Hospitals Examples
Figure Clinics Examples
Table Global Ankylosing Spondylitis Drug Sales (K Units) Comparison by Application (2014-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) by Application (2014-2019)
Table Global Ankylosing Spondylitis Drug Sales Share (%) by Application (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Application (2014-2019)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) by Application in 2018
Figure Global Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Ankylosing Spondylitis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Ankylosing Spondylitis Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Ankylosing Spondylitis Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Ankylosing Spondylitis Drug Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Ankylosing Spondylitis Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Cimzia Sales Growth Forecast
Figure Enbrel Sales Growth Forecast
Table Global Ankylosing Spondylitis Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales Forecast by Application (2019-2025)
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Forecast in Hospitals
Figure Global Ankylosing Spondylitis Drug Sales (K Units) Forecast in Clinics
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Ankylosing Spondylitis Drug Manufacturing Cost Structure
Figure Ankylosing Spondylitis Drug Industrial Chain Analysis
Table Distributors List
Table Ankylosing Spondylitis Drug Downstream Customers
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"